First Affirmative Financial Network’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$340K Buy
4,903
+259
+6% +$18K 0.21% 139
2024
Q4
$399K Buy
4,644
+233
+5% +$20K 0.23% 118
2024
Q3
$525K Sell
4,411
-255
-5% -$30.4K 0.29% 88
2024
Q2
$666K Sell
4,666
-233
-5% -$33.3K 0.46% 44
2024
Q1
$629K Sell
4,899
-817
-14% -$105K 0.46% 48
2023
Q4
$591K Sell
5,716
-1,150
-17% -$119K 0.47% 47
2023
Q3
$624K Sell
6,866
-340
-5% -$30.9K 0.61% 32
2023
Q2
$583K Sell
7,206
-818
-10% -$66.2K 0.58% 39
2023
Q1
$639K Sell
8,024
-682
-8% -$54.3K 0.74% 23
2022
Q4
$589K Sell
8,706
-412
-5% -$27.9K 0.71% 23
2022
Q3
$454K Sell
9,118
-904
-9% -$45K 0.58% 37
2022
Q2
$558K Sell
10,022
-270
-3% -$15K 0.63% 35
2022
Q1
$571K Buy
10,292
+810
+9% +$44.9K 0.55% 44
2021
Q4
$531K Buy
9,482
+486
+5% +$27.2K 0.49% 49
2021
Q3
$432K Buy
+8,996
New +$432K 0.44% 58